Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 5
2021 2
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial.
Abdullahi SU, Jibir BW, Bello-Manga H, Gambo S, Inuwa H, Tijjani AG, Idris N, Galadanci A, Hikima MS, Galadanci N, Borodo A, Tabari AM, Haliru L, Suleiman A, Ibrahim J, Greene BC, Ghafuri DL, Rodeghier M, Slaughter JC, Kirkham FJ, Neville K, Kassim A, Trevathan E, Jordan LC, Aliyu MH, DeBaun MR. Abdullahi SU, et al. Among authors: haliru l. Lancet Haematol. 2022 Jan;9(1):e26-e37. doi: 10.1016/S2352-3026(21)00368-9. Lancet Haematol. 2022. PMID: 34971579 Free PMC article. Clinical Trial.
Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework.
Ghafuri DL, Abdullahi SU, Dambatta AH, Galadanci J, Tabari MA, Bello-Manga H, Idris N, Inuwa H, Tijjani A, Suleiman AA, Jibir BW, Gambo S, Gambo AI, Khalifa Y, Haliru L, Abdulrasheed S, Zakari MA, Greene BC, Trevathan E, Jordan LC, Aliyu MH, Baumann AA, DeBaun MR. Ghafuri DL, et al. Among authors: haliru l. J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e56-e61. doi: 10.1097/MPH.0000000000002179. J Pediatr Hematol Oncol. 2022. PMID: 34001783 Free PMC article. Clinical Trial.
Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.
Isa H, Adegoke S, Madu A, Hassan AA, Ohiaeri C, Chianumba R, Brown B, Okocha E, Ugwu N, Diaku-Akinwumi I, Adeyemo T, Kuliya-Gwarzo A, Dogara L, Lawal H, Tanko Y, Ladu A, Kangiwa U, Ekwem L, Oniyangi S, Wakama T, Umoru D, Olanrewaju O, Akinola N, Nnebe-Agumadu U, Asala S, Adekile A, Olaniyi J, Sangeda R, Sickle Africa Data Coordinating Center SADaCC, Nnodu O. Isa H, et al. Among authors: lawal h. Blood Cells Mol Dis. 2020 Sep;84:102438. doi: 10.1016/j.bcmd.2020.102438. Epub 2020 Apr 23. Blood Cells Mol Dis. 2020. PMID: 32504882 Free PMC article.
Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
Bello-Manga H, Galadanci AA, Abdullahi S, Ali S, Jibir B, Gambo S, Haliru L, Jordan LC, Aliyu MH, Rodeghier M, Kassim AA, DeBaun MR, Galadanci NA. Bello-Manga H, et al. Among authors: haliru l. Br J Haematol. 2020 Sep;190(6):939-944. doi: 10.1111/bjh.16746. Epub 2020 May 16. Br J Haematol. 2020. PMID: 32415792 Free PMC article. Clinical Trial.
Corrigendum to "Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database" [Blood Cells, Molecules and Diseases (2020) Start page-End page/202438].
Isa H, Adegoke S, Madu A, Hassan AA, Ohiaeri C, Chianumba R, Brown B, Okocha E, Ugwu N, Diaku-Akinwumi I, Adeyemo T, Kuliya-Gwarzo A, Dogara L, Lawal H, Tanko Y, Ladu A, Kangiwa U, Ekwem L, Oniyangi S, Wakama T, Umoru D, Olanrewaju O, Akinola N, Nnebe-Agumadu U, Asala S, Adekile A, Olaniyi J, Sangeda R; Sickle Africa Data Coordinating Center (SADaCC); Nnodu O. Isa H, et al. Among authors: lawal h. Blood Cells Mol Dis. 2021 May;88:102480. doi: 10.1016/j.bcmd.2020.102480. Epub 2020 Jul 29. Blood Cells Mol Dis. 2021. PMID: 32739321 No abstract available.
Barriers and Facilitators to a Task-Shifted Stroke Prevention Program for Children with Sickle Cell Anemia in a Community Hospital: A Qualitative Study.
Bello-Manga H, Haliru L, Ahmed K, Ige S, Musa H, Muhammad-Idris ZK, Monday B, Sani AM, Bonnet K, Schlundt DG, Varughese T, Tabari AM, DeBaun MR, Baumann AA, King AA. Bello-Manga H, et al. Among authors: haliru l. Res Sq [Preprint]. 2023 Jul 3:rs.3.rs-2985921. doi: 10.21203/rs.3.rs-2985921/v1. Res Sq. 2023. PMID: 37461538 Free PMC article. Updated. Preprint.
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.
Abdullahi SU, Wudil BJ, Bello-Manga H, Musa AB, Gambo S, Galadanci NA, Aminu H, Tijjani Gaya A, Sanusi S, Tabari MA, Galadanci A, Borodo A, Abba MS, Dambatta AH, Haliru L, Gambo A, Cassell H, Rodeghier M, Ghafuri DL, Covert Greene BV, Neville K, Kassim AA, Kirkham F, Trevathan E, Jordan LC, Aliyu MH, DeBaun MR. Abdullahi SU, et al. Among authors: haliru l. Pediatr Hematol Oncol. 2021 Feb;38(1):49-64. doi: 10.1080/08880018.2020.1810183. Epub 2020 Nov 25. Pediatr Hematol Oncol. 2021. PMID: 33236662 Free PMC article. Clinical Trial.
Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
Galadanci AA, Galadanci NA, Jibir BW, Abdullahi SU, Idris N, Gambo S, Ali Abubakar SA, Kabo NA, Bello-Manga H, Haliru L, Bashir I, Aliyu MH, Galadanci JA, DeBaun MR. Galadanci AA, et al. Among authors: haliru l. Am J Hematol. 2019 Nov;94(11):E305-E307. doi: 10.1002/ajh.25616. Epub 2019 Sep 11. Am J Hematol. 2019. PMID: 31423630 Free PMC article. No abstract available.
12 results